Enzon Pharmaceuticals (ENZN) Social Stream

Featured Post From StockTwits About ENZN

$ENZN "With the closing of the Amoun deal, we will be able to further reduce overall Bausch Health debt," said Joseph C. Papa, chairman and CEO, Bausch Health. "We are continuing to pursue all opportunities to drive value for our shareholders, including preparing for the spinoff of Bausch + Lomb."